Literature DB >> 12591782

Incidence, clearance and predictors of human papillomavirus infection in women.

John W Sellors1, Tina L Karwalajtys, Janusz Kaczorowski, James B Mahony, Alice Lytwyn, Sylvia Chong, Joanna Sparrow, Attila Lorincz.   

Abstract

BACKGROUND: Persistent infection with carcinogenic human papillomavirus (HPV) is linked to high-grade lesions and cervical cancer. To better understand the natural history of HPV, we sought to determine the rates of incident and cleared carcinogenic HPV infection, by age, among women aged 15-49 years and to explore risk factors for incident infection.
METHODS: Women enrolled in an earlier HPV prevalence survey (500 of 800 who were HPV-negative and all 121 who were HPV-positive) were invited to participate in follow-up HPV testing at their periodic health examination one year later. A cervical soft-brush specimen for HPV testing and a smear for cytologic examination were obtained, and participants completed a questionnaire on their demographic characteristics and sexual history.
RESULTS: Two hundred and fifty-three (50.6%) previously HPV-negative women and 54 (44.6%) previously HPV-positive women were retested. The mean interval between visits was 14.0 (standard deviation 2.0, median 13.5, range 9.0-21.3) months. Incident HPV infection occurred in 11.1% (28/253) of the women overall, with the highest rate, 25.0% (6/24), in the 15-19-year age group. In the univariate analyses, risk factors for incident HPV were the median number of sexual partners in the past year (< or = 1 v. > or = 2: odds ratio [OR] 8.2, 95% confidence interval [CI] 3.0-22.2; p < 0.001) and the median number of sexual partners over a lifetime (> 3 v. < or = 3: OR 3.0, 95% CI 1.2-7.2; p = 0.014). In multivariate logistic regression modelling adjusted for age, median number of sexual partners in the past year, median number of sexual partners over a lifetime, marital status, current smoking and current use of oral contraceptives, only the median number of sexual partners in the past year remained significantly associated with incidence (OR 6.2, 95% CI 1.6-24.5; p = 0.009). Of the previously HPV-positive women, 51.9% (28/54) had cleared the infection.
INTERPRETATION: Incident infection with carcinogenic HPV was highest in women aged 15-19 years, and risk factors were consistent with a sexually transmitted infection. A large proportion of the women who were HPV-positive appeared to have cleared the infection after one year.

Entities:  

Mesh:

Year:  2003        PMID: 12591782      PMCID: PMC143547     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  15 in total

1.  Short-term fluctuations in the detection of cervical human papillomavirus DNA.

Authors:  C M Wheeler; C E Greer; T M Becker; W C Hunt; S M Anderson; M M Manos
Journal:  Obstet Gynecol       Date:  1996-08       Impact factor: 7.661

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

Review 3.  Molecular methods for the detection of human papillomavirus infection.

Authors:  A T Lörincz
Journal:  Obstet Gynecol Clin North Am       Date:  1996-09       Impact factor: 2.844

4.  Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS).

Authors:  Mark E Sherman; Mark Schiffman; J Thomas Cox
Journal:  J Natl Cancer Inst       Date:  2002-01-16       Impact factor: 13.506

5.  Natural history of cervicovaginal papillomavirus infection in young women.

Authors:  G Y Ho; R Bierman; L Beardsley; C J Chang; R D Burk
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

6.  Risk factors for HPV DNA detection in middle-aged women.

Authors:  N Muñoz; I Kato; F X Bosch; J Eluf-Neto; S De Sanjosé; N Ascunce; M Gili; I Izarzugaza; P Viladiu; M J Tormo; P Moreo; L C Gonzalez; L Tafur; J M Walboomers; K V Shah
Journal:  Sex Transm Dis       Date:  1996 Nov-Dec       Impact factor: 2.830

7.  Human papillomavirus infection is transient in young women: a population-based cohort study.

Authors:  M Evander; K Edlund; A Gustafsson; M Jonsson; R Karlsson; E Rylander; G Wadell
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

8.  Persistence of type-specific human papillomavirus infection among cytologically normal women.

Authors:  A Hildesheim; M H Schiffman; P E Gravitt; A G Glass; C E Greer; T Zhang; D R Scott; B B Rush; P Lawler; M E Sherman
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

9.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.

Authors:  L A Koutsky; K K Holmes; C W Critchlow; C E Stevens; J Paavonen; A M Beckmann; T A DeRouen; D A Galloway; D Vernon; N B Kiviat
Journal:  N Engl J Med       Date:  1992-10-29       Impact factor: 91.245

10.  Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.

Authors:  C Hankins; F Coutlée; N Lapointe; P Simard; T Tran; J Samson; L Hum
Journal:  CMAJ       Date:  1999-01-26       Impact factor: 8.262

View more
  62 in total

1.  Transmission of HPV.

Authors:  Sarah Giles
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

2.  Concomitant Chlamydia trachomatis and human papilloma virus infection cannot be attributed solely to sexual behaviour.

Authors:  V Verhoeven; M Baay; J Weyler; D Avonts; F Lardon; P Van Royen; J B Vermorken
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-18       Impact factor: 3.267

3.  Smoking and human papillomavirus (HPV) infection in the HPV in Men (HIM) study.

Authors:  Matthew B Schabath; Luisa L Villa; Eduardo Lazcano-Ponce; Jorge Salmerón; Manuel Quiterio; Anna R Giuliano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-20       Impact factor: 4.254

Review 4.  Human papillomavirus infections in primary care.

Authors:  Folashade Ogunmodede; Steven H Yale; Bruce Krawisz; Gregory C Tyler; Anthony C Evans
Journal:  Clin Med Res       Date:  2007-12-17

Review 5.  Cervical cancer screening.

Authors:  Dorothy J Wiley; Bradley J Monk; Emmanuel Masongsong; Kristina Morgan
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

6.  HPV vaccination discourses and the construction of "at-risk" girls.

Authors:  Geneviève Rail; Luisa Molino; Caroline Fusco; Moss Edward Norman; LeAnne Petherick; Jessica Polzer; Fiona Moola; Mary Bryson
Journal:  Can J Public Health       Date:  2018-08-03

7.  Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Zoe R Edelstein; Craig Meyers; Jesse Ho; Mark Schiffman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

8.  Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women.

Authors:  Ann Nielsen; Thomas Iftner; Christian Munk; Susanne K Kjaer
Journal:  Sex Transm Dis       Date:  2009-10       Impact factor: 2.830

Review 9.  The impact of smoking on HPV infection and the development of anogenital warts.

Authors:  Reto Kaderli; Beat Schnüriger; Lukas E Brügger
Journal:  Int J Colorectal Dis       Date:  2014-06-17       Impact factor: 2.571

10.  The laboratory diagnosis of genital human papillomavirus infections.

Authors:  François Coutlée; Danielle Rouleau; Alex Ferenczy; Eduardo Franco
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.